Biolinerx Ltd's Customers Performance

Name: Biolinerx Ltd Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

BLRX

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


BLRX's Source of Revenues		During the corresponding time, Biolinerx Ltd saw a revenue deteriorated by -95.92 % year on year, While revenue at the Biolinerx Ltd 's corporate clients • List of BLRX Customers

for the same period Biolinerx Ltd revnue deteriorated by -95.92 % year on year,

• List of BLRX Customers

Biolinerx Ltd's Business Units


U S		100 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Biolinerx Ltd's Comment on Sales, Marketing and Customers

The company utilizes contract manufacturers for the clinical and pre-clinical development of GLIX1 and motixafortide. Manufacturing responsibility for motixafortide is being transferred to Ayrmid. Under the Gloria License Agreement, the Gloria Licensee may also manufacture motixafortide in the future. The company retains rights to manufacture motixafortide for clinical development and commercialization in specific indications and territories. Due to long lead times and costs, manufacturing is expected to be conducted by single contract manufacturers. The company's laboratories in Modi’in, Israel support research and development but are not compliant with current good manufacturing practices (cGMP) and therefore cannot independently manufacture drug substances or products for clinical trials or commercial distribution. Third-party manufacturers must comply with cGMP and are subject to FDA and other regulatory inspections to ensure compliance. Non-compliance with regulations can result in legal and regulatory actions.

Biolinerx Ltd’s Comment on Sales, Marketing and Customers

BLRX's Stock Performance relative to it's Customers

BLRX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Biolinerx Ltd	6,212.49	1.18	-2.03	24
SUBTOTAL	0.00	0.00	0.00	-

Sources: Biolinerx Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Biolinerx Ltd’s corporate clients.
For your research, we’ve provided 9 tables on Biolinerx Ltd corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.